TherapeuticsMD
TXMD
148 hedge funds and large institutions have $489M invested in TherapeuticsMD in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 29 reducing their positions, and 19 closing their positions.
103% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 29
26% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 19
1% more funds holding
Funds holding: 146 → 148 (+2)
0.02% less ownership
Funds ownership: 1.59% → 1.57% (-0.02%)
47% less capital invested
Capital invested by funds: $932M → $489M (-$442M)
48% less call options, than puts
Call options by funds: $2.99M | Put options by funds: $5.77M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
+$8.29M |
| 2 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$7.89M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$7.49M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$7.36M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$11.6M |
| 2 |
Bank of New York Mellon
New York
|
-$10.7M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$5.48M |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$4.61M |
| 5 |
JP Morgan Chase
New York
|
-$3.78M |
TXMD Hedge Fund Activity: Q2 2019 in Review
148 of the 4,624 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q2 2019, worth a combined $489M — down 47% from $932M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new TXMD positions and 19 closed out — a net gain of 5 holders — while 59 added to existing stakes and 29 trimmed.
The largest buyer was SG Americas Securities, adding an estimated $8.29M. The largest seller was Millennium Management, cutting an estimated $11.6M.
- 148 institutional investors held TherapeuticsMD (TXMD) as of Q2 2019, up from 146 in Q1 2019.
- Funds reported $489M of TherapeuticsMD stock for Q2 2019, down 47% quarter-over-quarter.
- 24 funds opened new TherapeuticsMD positions in Q2 2019 and 19 closed out, a net change of +5 holders.
- The largest TherapeuticsMD buyer in Q2 2019 was SG Americas Securities, an estimated $8.29M added.
- The largest TherapeuticsMD seller in Q2 2019 was Millennium Management, an estimated $11.6M sold.
Based on aggregated 13F filings for Q2 2019.